Relapsed Peripheral T-Cell Lymphoma: Clinical Trials

1 trial for Relapsed Peripheral T-Cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow Relapsed Peripheral T-Cell Lymphoma: new trials by email Literature Review of Relapsed Peripheral T-Cell Lymphoma trials Research Report on Relapsed Peripheral T-Cell Lymphoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
Biopsy, Biospecimen Collection, Bone Marrow Biopsy - Peripheral T Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma
Phase 1RecruitingMayo Clinic212024-01-052026-07-01

Narrower conditions

Lymphoma, Large-Cell, Anaplastic (1)  ·  Lymphoma, T-Cell (1)  ·  Lymphoma, T-Cell, Peripheral (1)  ·  Mycosis Fungoides (1)

Broader conditions

Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoma, T-Cell, Cutaneous (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Biopsy (1)  ·  Disulfides (1)  ·  Immunoglobulin G (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Photons (1)  ·  Specimen Handling (1)  ·  X-Rays (1)  ·  cemiplimab (1)  ·  ruxolitinib (1)  ·  sodium-iodide symporter (1)

Sponsors

Mayo Clinic (1)

Countries

United States (1)

Top investigators

Kah Whye Peng, PhD (1)  ·  Nora Bennani, MD (1)

Results publications

PMID 35175355

NIH funding

P50CA186781 (1), R01CA262613 (1)